Drug Free Solution, Inc.
DSOL
$0.0002
$0.000.00%
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Revenue | 2.10K | 2.10K | -- | -- | -1.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.10K | 2.10K | -- | -- | -1.90K |
| Cost of Revenue | 212.60K | 212.60K | 210.00K | 194.80K | 107.70K |
| Gross Profit | -210.50K | -210.50K | -210.00K | -194.80K | -109.60K |
| SG&A Expenses | 629.10K | 623.50K | 562.80K | 782.60K | 367.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 869.80K | 864.20K | 772.90K | 977.50K | 475.10K |
| Operating Income | -867.70K | -862.10K | -772.90K | -977.50K | -477.00K |
| Income Before Tax | -867.70K | -862.10K | -772.90K | -977.50K | -554.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.87 | -0.86 | -0.77 | -0.98 | -0.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -867.70K | -862.10K | -772.90K | -977.50K | -554.10K |
| EBIT | -867.70K | -862.10K | -772.90K | -977.50K | -477.00K |
| EBITDA | -862.10K | -859.20K | -771.30K | -975.90K | -475.60K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 376.26M | 356.49M | 316.68M | 284.84M | 255.58M |
| Average Diluted Shares Outstanding | 376.26M | 356.49M | 316.68M | 284.84M | 255.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
